February 18, 2026
Headlines

What Analysts Are Saying About Ligand Pharmaceuticals Stock

Sumain Faisal01 mins

Latest Ratings for LGND

Date Firm Action From To
Feb 2022 Benchmark Maintains Buy
Feb 2022 Barclays Maintains Overweight
Sep 2021 Barclays Maintains Overweight

View More Analyst Ratings for LGND

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News